The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients
Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma
Cancer Res Treat. 2021;53(2):339-354.   Published online 2020 Nov 6     DOI:
Citations to this article as recorded by Crossref logo
Vascular Normalization to Improve Treatment of COVID-19: Lessons from Treatment of Cancer
Lance L. Munn, Triantafyllos Stylianopoulos, Natalie K. Jain, C. Corey Hardin, Melin J. Khandekar, Rakesh K. Jain
Clinical Cancer Research.2021; 27(10): 2706.     CrossRef